42231 Investors following Ranbaxy Labs. Share this News with them.
0
Like this story, share it with millions of investors on M3
Ranbaxy Q3 net profit seen at Rs 179cr
Ranbaxy Laboratories is to announce its Q3CY06 results. According to CNBC-TV18 estimates, the company's net profit is expected to go up at Rs 179.15 crore versus Rs 18.4 crore.
Ranbaxy Laboratories is to announce its Q3CY06 results. According to CNBC-TV18 estimates, the company's net profit is expected to go up at Rs 179.15 crore (Rs 1.79 billion) versus Rs 18.4 crore (Rs 184 million).
Its gross revenues are seen going up 22.44% from Rs 1303.9 crore (Rs 13.03 billion) to Rs 1596.5 crore (Rs 15.96 billion).
The EBITDA margin is seen at 19% in the third quarter versus 18% in the second quarter.
